Osprey Pharmaceuticals USA Inc.
Industry
- Biotechnology
- Large Molecule
- Pharmaceuticals
- Medical Devices
- Surgical Equipment & Devices
See more in Biomedtracker
Latest on Osprey Pharmaceuticals USA Inc.
In Vivo
IN VITRO DIAGNOSTICS Financings Cancer Genetics Inc. Molecular diagnostics firm Cancer Genetics Inc. entered a financing agreement with Aspire Capital, through which Aspire will purchase, over the
In Vivo
• By Beth Allan, Steven Muntner, Maureen Riordan, and Deanna Kamienski
IN VITRO DIAGNOSTICS Mergers & Acquisitions Bio-Techne Corp. Advanced Cell Diagnostics Inc. Bio-Techne Corp. paid $250mm cash to acquire privately held molecular pathology firm Advanced Cell Dia
Scrip
• By Ian Haydock
The Medical Research Commercialisation Fund 3 (MRCF3) has just been closed by Brandon Capital Partners with a total of AUD200 million ($154 million) from a variety of partners, including previous MRCF